Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
ConditionRobotic Lung Surgery
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-90
SponsorThe Cooper Health System
About this trial
This study will assess analgesia after robotic lung surgery. Subjects will be randomized to receive wound infiltration and intercostal nerve block with either liposomal bupivacaine or bupivacaine/epinephrine + dexamethasone. Liposomal bupivacaine is a newer local anesthetic product and has not been compared to a combination of bupivacaine/epinephrine + dexamethasone in the context of pain control after robotic lung surgery.
Eligibility criteria
Qualifiers
undergoing robotic wedge resection or lobectomy for lung mass(es)
Disqualifiers
emergency case
history of opiate abuse
chronic pain syndrome
intravenous drug use
Trial design
Treatments tested in this trial
- Intercostal nerve block and wound infiltration with liposomal bupivacaine
- Intercostal nerve block and wound infiltration with bupivacaine/epinephrine + dexamethasone
Treatment groups
34 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov